Cytek Biosciences (CTKB) Cash from Operations (2020 - 2026)
Cytek Biosciences (CTKB) posted Cash from Operations of 2736000.0 for Q1 2026, down 254.86% on a QoQ basis from 771000.0 in Q4 2025, and down 2088.8% year-over-year from 137570.39 in Q1 2025.
Cytek Biosciences (CTKB) Cash from Operations (2020 - 2026) Analysis & Trends
Cytek Biosciences' Cash from Operations history runs 7 years deep, the most recent figure standing at 2736000.0 for Q1 2026.
- Quarterly Cash from Operations fell 2088.8% year-over-year to 2736000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7297000.0 (down 134.26% YoY) and the FY2025 annual result came in at 4686000.0, down 118.46% from the prior year.
- Cash from Operations was 2736000.0 for Q1 2026 at Cytek Biosciences, down from 771000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 13221000.0 in Q3 2024 and bottomed at 9440000.0 in Q2 2022.
- A 5-year average of 647470.59 and a median of 125000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2024 — Cash from Operations soared 411.89% — and 2026, when it slumped 2088.8%.
- Cytek Biosciences' Cash from Operations stood at 6193000.0 in 2022, then surged by 53.59% to 9512000.0 in 2023, then tumbled by 79.01% to 1997000.0 in 2024, then tumbled by 138.61% to 771000.0 in 2025, then slumped by 254.86% to 2736000.0 in 2026.
- Business Quant data shows CTKB's Cash from Operations at 2736000.0 in Q1 2026, 771000.0 in Q4 2025, and 3898000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | -2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.74 Mn |
| Mar 31, 2026 | -2.74 Mn |
| Dec 31, 2025 | -771,000.00 |
| Dec 31, 2025 | -771,000.00 |
| Sep 30, 2025 | -3.90 Mn |
| Sep 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 108,000.00 |
| Mar 31, 2025 | -125,000.00 |
| Mar 31, 2025 | -125,000.00 |
| Dec 31, 2024 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 13.22 Mn |
| Sep 30, 2024 | 13.22 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 9.51 Mn |
| Dec 31, 2023 | 9.51 Mn |